Cancer-associated retinopathy.

  title={Cancer-associated retinopathy.},
  author={Scott M Goldstein and Nasreen A. Syed and Ann H. Milam and Albert M. Maguire and Thomas J. Lawton and Charles W Nichols},
  journal={Archives of ophthalmology},
  volume={117 12},
Patients with systemic cancer may have a variety of ocular complaints. Most commonly these are metastases or adverse effects of therapy. Paraneoplastic syndromes, like cancer-associated retinopathy, rarely cause ophthalmic symptoms. We describe a patient with a malignant mixed mullerian tumor and cancer-associated retinopathy who had circulating serum antibodies to recoverin and cells positive for recoverin in the tumor. We discuss the typical clinical symptoms as well as the pathophysiology of… CONTINUE READING


Publications citing this paper.
Showing 1-9 of 9 extracted citations


Publications referenced by this paper.
Showing 1-10 of 28 references

Commonalities and diversity in the immune-response of cancer-associated retinopathy (CAR) patients [ARVO abstract

  • CE Thirkill, JL Keltner
  • Invest Ophthalmol Vis Sci
  • 1997

IVIg protocol : reversal of carcinoma - associated retinopathy ( CAR ) induced blindness with IVIg

  • J Guy, N Aptsiauri
  • Neurology
  • 1997

IVIg protocol: reversal of carcinoma-associated retinopathy (CAR) induced blindness with IVIg. Neurology

  • J Guy, N. Aptsiauri
  • 1997
1 Excerpt

Similar Papers

Loading similar papers…